Inhibitory effects of hyaluronan on [14C]arachidonic acid release from labeled human synovial fibroblasts

Jpn J Pharmacol. 1992 Oct;60(2):79-84. doi: 10.1254/jjp.60.79.

Abstract

The effects of hyaluronan (HA) on the release of arachidonic acid (AA) from phospholipids induced by bradykinin in synovial fibroblasts of osteoarthritic patients were examined. HA inhibited [14C]AA release from prelabeled synovial cells stimulated with and without bradykinin 1 hr after incubation with HA and thereafter. The inhibitory effects of HA on [14C]AA release were dependent on the concentration and molecular weight of HA. However, inhibition of [14C]AA release by HA was not merely due to the viscosity of HA. The [14C]AA release induced by calcium-ionophore A23187 was also inhibited by HA with a high molecular weight. In addition, HA did not affect [14C]AA uptake by the cells. Our results suggest that HA with a high molecular weight elicits anti-inflammatory effects, at least in part, by inhibiting AA release in inflamed joints.

MeSH terms

  • Arachidonic Acid / metabolism*
  • Bradykinin / pharmacology
  • Calcimycin / pharmacology
  • Fibroblasts / metabolism
  • Humans
  • Hyaluronic Acid / pharmacology*
  • Lipid Metabolism
  • Methylcellulose / pharmacology
  • Molecular Weight
  • Osteoarthritis / drug therapy
  • Synovial Fluid / cytology
  • Synovial Fluid / metabolism*
  • Viscosity

Substances

  • Arachidonic Acid
  • Calcimycin
  • Hyaluronic Acid
  • Methylcellulose
  • Bradykinin